SulfacetamideThird Party Manufacturing in India

Sulfacetamide works as a competitive antagonist against para-aminobenzoic acid (PABA), an essential component required for bacterial survival. By blocking PABA binding, it inhibits the enzyme dihydropteroate synthase, halting the synthesis of dihydrofolic acid. This disruption prevents bacteria from producing folic acid, which is required for purine, pyrimidine, and DNA synthesis, thereby stopping bacterial replication. Unlike bactericidal antibiotics that rupture cell walls, this bacteriostatic agent stops the growth of susceptible micro-organisms, allowing the host's immune system to eliminate the infection naturally. It is highly effective and well-tolerated.

Therapeutic Uses

• Superficial Ocular Infections: Treats conjunctivitis, blepharitis, and other acute infections caused by susceptible bacteria.
• Trachoma Management: Serves as an adjunctive therapy alongside systemic treatments for Chlamydia trachomatis infections.
• Prophylactic Injury Care: Prevents bacterial colonization following minor abrasions or foreign body removal from the eye.

Why Manufacturers Choose Sulfacetamide

Sulfacetamide remains a reliable, cost-effective option for primary eye care portfolios due to its long history of clinical use and stable raw material availability. Formulating this molecule requires careful pH stabilization to prevent active ingredient crystallization under CAS number 144-80-9 guidelines. Our partner facilities utilize advanced manufacturing technologies to produce clear, stable solutions that meet strict WHO-GMP certified standards. Partnering with Celesta for Sulfacetamide third party manufacturing in India helps your brand deliver dependable, accessible infectious care solutions.